(4S,5R)-3-((2S,3R)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-(tert-butoxy)butanoyl)-2,2,5-trimethyloxazolidine-4-carboxylic acid, 97%, 10g

1-(4-BROMO-2-METHYLPHENYL)ETHANONE, 95.0%, 100g

2-Amino-4-oxo-4,7-dihydro-3H-pyrrolo[2,3-d]pyrimidine-5-carbonitrile, 95.0%, 10g

4-(chlorosulfonyl)-3-fluorobenzoic acid, 97.0%, 100mg

(R)-Chroman-3-amine hydrochloride, 95.0%, 100mg

3-Bromo-5-nitrophenol, 95.0%, 1g

2,6-Dimethoxypyrimidine-4-carboxylic acid, 95.0%, 250mg

Combretastatin A4, 98.0%, 25mg

(2S,3R,4R,5S,6R)-6-(Hydroxymethyl)-5-(((2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)oxy)tetrahydro-2H-pyran-2,3,4-triol, 98.0%, 25g

Ethyl 1-Bromocyclobutanecarboxylate>96.0%(GC)1g

2-Chloro-4-methylpyrimidine-5-carboxylic acid, 95.0%, 500mg

(1R,4R)-4-(Ethoxycarbonyl)cyclohexanecarboxylic acid, 95.0%, 1g

5-(4-fluoropyrrolidin-2-yl)-3-methyl-1,2,4-oxadiazole hydrochloride, 95.0%, 250mg